Hollister Biosciences Inc. (CSE: HOLL) (OTC: HSTRF) (FRANKFURT: HOB) (the
Company ,
Hollister Cannabis Co. or
Hollister ) a diversified cannabis branding company with products in over 280 dispensaries throughout California, and over 90 dispensaries throughout Arizona, is pleased to provide an update on its Q4, 2020 performance.
Q4 2020 Update
st, 2020 and ending December 31
st, 2020, Hollister reports that it generated record quarterly revenue of CDN$14.93 million and CDN$2.53 million in EBITDA from its product line of pre-rolls, concentrates, distillates, solvent-free bubble hash, pre-packaged flower, tinctures and vape products. The Company cautions that revenue and EBITDA figures have not yet been audited and are based on reports prepared by management.
milestone | Benzinga benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.
Uber Technologies Inc. (NYSE: UBER) second quarter 2019 report probably won t receive the accolades garnered by its ride-hailing competitor, Lyft Inc (NYSE: LYFT).
Uber s second quarter as a public company saw a loss of $4.72 per share, which was much worse than the $2.01 per share loss reported a. Read More.
Hollister Biosciences 100% Owned Subsidiary Venom Extracts Achieves Final $40 Million Revenue Milestone
Hollister Biosciences Inc. a diversified cannabis branding company with products in over 230 dispensaries throughout California and over 80 dispensaries throughout Arizona is pleased to announce that further to the news release dated March 30 th 2020, its 100% owned subsidiary, Venom Extracts has achieved its second of two revenue milestones in accordance with the terms of the definitive agreement that was entered …
Hollister Biosciences Inc. (CSE: HOLL) (OTCPK: HSTRF) (FRANKFURT: HOB) (the ” Company “, ” Hollister Cannabis Co .” or ” Hollister “) a diversified cannabis branding company with products in over 230 dispensaries throughout California and over 80 dispensaries throughout Arizona is pleased to announce that further to the news release dated March 30 th 2020, its 100% owned subsidiary, Venom Extracts (” Venom “) has achieved its second of two revenue mi